Targeting IGF-1R reduces secondary lymphedema in mice
Feb. 12, 2025
Secondary lymphedema occurs when, after surgery or radiotherapy, the lymphatic system cannot drain interstitial fluid effectively, leading to inflammation and fluid accumulation in the limbs. Previous research has shown that insulin-like growth factor 1 (IGF-1) contributes to the promotion of lymphatic remodeling through IGF-1 receptor (IGF-1R) signaling.